Wistar’s major accomplishments in 2022 are made possible by the dedicated and innovative scientists, staff, and generous donors committed to improve the health of all through biomedical research. Fro…
In 1979, at the dawn of the biotechnology era, The Wistar Institute was awarded the first of several patents for the production of monoclonal antibodies against tumors and influenza virus antigens, w…
When biomedical scientists think about the Pew Charitable Trusts, the first thing that probably comes to mind for many is the Pew Scholars Program in the Biomedical Sciences. The program, which launc…
For more than a century, The Wistar Institute Cancer Center has led many of the major advances in cancer research and treatment. Wistar scientists were among the first to describe genetic abnormaliti…
Since 2000, students at the Community College of Philadelphia have been participating in a summer program at The Wistar Institute to learn the ins and outs of being a research technician. Graduates o…
For as far back as he can remember, Roger Malerba wanted to be a physician. He majored in biology at La Salle University and even shadowed doctors to learn more about orthopedic surgery, the specialt…
Biomedical research knows no borders. Scientific exchanges across academic institutions around the world enrich knowledge, accelerate the pace of discovery, and facilitate the development of new cure…
Luis J. Montaner, D.V.M., D.Phil, and his team are making tremendous strides studying the ability of natural killer (NK) cells, a type of immune cell, to wipe out HIV-infected cells. Meanwhile, other…
Dr. Carolyn Bertozzi received the 2022 Helen Dean King Award from The Wistar Institute in recognition of her outstanding biomedical research on understanding how sugars that coat our cells impact dis…
The evolution of machine learning and artificial intelligence is changing the way the contemporary lab looks and functions. Researchers today are discovering that breakthroughs can happen not only at…
